in-pharmatechnologist presents a roundup of the latest drug sector manufacturing expansions with Sanofi Aventis, Takeda, Cerbios and Alliance Medical all adding capacity.
French drug major Sanofi Aventis has unveiled plans for a €200m ($268m) biotechnology investment at its manufacturing facility in Vitry-sur-Seine near Paris, under its collaborative Biolaunch project.